Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Long-term Follow-up Study of Patients Who Received MB-105

This study is to fulfil the regulatory requirement for 15-year follow-up for patients treated with MB-105 in any study

Participants needed: 40
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: March Biosciences IncUpdated: Jan 14, 2026
Eligibility criteria

Not listed

Status: Recruiting

MB-105 in Patients With CD5 Positive T-cell Lymphoma

This is a single arm, two-stage, Phase 2, open-label, multicenter study of MB-105 in patients with CD5 Positive (CD5+) Relapsed / Refractory T-cell Lymphoma (r/r TCL). This study will apply a Simon two-stage optimal design.

Participants needed: 46
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: March Biosciences IncUpdated: Oct 3, 2025Locations: 12
Eligibility criteria

Male or female ≥ 18 years of age. [+24]

Sezary syndrome. For other tumor types, if there is a suspicion of significant c... [+19]